FINWIRES · TerminalLIVE
FINWIRES

$ALGN

6 stories mentioning ALGNUpdated 39d ago

Every FINWIRES story that references ALGN, newest first.

Research

Research Alert: CFRA Maintains Hold Rating On Align Technology, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target to $189 from $193. This new target is 16.7x our 2026 EPS estimate, above ALGN's one-year historical forward average of 15.7x but well below its three- and five-year averages of 24.3x and 31.4x, respectively. We raise our 2026 EPS estimate by $0.06 to $11.34 and our 2027 estimate by $0.15 to $12.36. While interest rates are expected to continue declining, we think North American patient volumes remain challenged in the current macro environment, with inflationary pressures weighing on consumer sentiment and elective medical spending. Average per case shipment price rose around 1% to $1,250 during Q1, up $10 sequentially and Y/Y, though ALGN guides for a 1%-2% decline in pricing during 2026.

$ALGN
Wire

Leerink Partners Adjusts Align Technology Price Target to $230 From $225

Align Technology (ALGN) has an average rating of overweight and mean price target of $208.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $173.84, Change: $-4.57, Percent Change: -2.56%

$ALGN
Wire

Evercore ISI Adjusts Align Technology Price Target to $220 From $200

Align Technology (ALGN) has an average rating of overweight and mean price target of $208.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $173.84, Change: $-4.57, Percent Change: -2.56%

$ALGN
Research

Research Alert: Align Technology: International Clear Aligner Volumes Support Q1 Sales, Eps Beat

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:ALGN delivered solid Q1 2026 results with revenues of $1.04B, up 6.2% Y/Y, above consensus, while adjusted EPS of $2.58 beat estimates by $0.29. Clear Aligner volumes rose 6.7% to 685.7k cases, with foreign exchange providing a $44.9M tailwind, though underlying constant currency growth was 2.6%. We view broad-based growth across customer segments positively, with orthodontist shipments up 7.4% and GP dentist volumes increasing 5.6%. The company is supported by a strong balance sheet with $1.06B in cash. Management reaffirmed full-year 2026 guidance for 3-4% revenue growth with mid-single digit Clear Aligner volume growth and non-GAAP operating margin of ~23.7%. Adjusted operating margin expanded 240 bps to 21.5%, reflecting restructuring benefits that should continue supporting profitability improvements. The company completed a $200M share repurchase and announced an additional $200M buyback starting May 2026, demonstrating shareholder-friendly capital allocation, in our view.

$ALGN
Wire

Morgan Stanley Adjusts Price Target on Align Technology to $188 From $169, Maintains Equalweight Rating

Align Technology (ALGN) has an average rating of overweight and mean price target of $205.85, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $187.77, Change: $-2.90, Percent Change: -1.52%

$ALGN
Research

Citigroup Initiates Align Technology at Buy With $240 Price Target

Align Technology (ALGN) has an average rating of overweight and mean price target of $200.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ALGN

Track with the FINWIRES app suite

FolioX
FolioX
Track ALGN in your portfolio
WheelAI
WheelAI
Analyze ALGN options with the wheel strategy
StockInsider
StockInsider
See market sentiment on ALGN